Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1986 Oct;78(4):940–946. doi: 10.1172/JCI112684

Autoantibodies to the low density lipoprotein receptor in a subject affected by severe hypercholesterolemia.

A Corsini, P Roma, D Sommariva, R Fumagalli, A L Catapano
PMCID: PMC423724  PMID: 3760193

Abstract

We studied a 32-yr-old man with a benign paraproteinemia (IgA) affected by severe nonfamilial hypercholesterolemia. In vitro experiments demonstrated that lipoprotein-deficient serum (LPDS) from the patient inhibited the binding of low density lipoprotein (LDL) to human skin fibroblasts cultured in vitro (up to 70%) whereas LPDS from controls had no effect. Removal of IgA from the patient's serum by immunoprecipitation with mono-specific antisera abolished the inhibition of LDL binding. IgA isolated from the serum of the patient by affinity chromatography inhibited, in a dose-dependent manner, the binding of LDL to human skin fibroblasts in vitro, thus showing an IgA-mediated effect. Ligand-blotting experiments demonstrated that the paraprotein directly interacts with the LDL receptor, thus inhibiting the binding of the lipoprotein. Treatment of the receptor protein with reducing agents blocked the interaction of the antibody with the LDL receptor. From these data we speculate that this autoantibody may be responsible for the severe nonfamilial hypercholesterolemia of the patient.

Full text

PDF
940

Images in this article

944Image
on p.944
945Image
on p.945

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Almon R. R., Andrew C. G., Appel S. H. Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors. Science. 1974 Oct 4;186(4158):55–57. doi: 10.1126/science.186.4158.55. [DOI] [PubMed] [Google Scholar]
  2. Beaumont J. L., Beaumont V. Autoimmune hyperlipidemia. Atherosclerosis. 1977 Apr;26(4):405–418. doi: 10.1016/0021-9150(77)90111-3. [DOI] [PubMed] [Google Scholar]
  3. Beaumont J. L., Berard M., Antonucci M., Delplanque B., Vranckx R. Inhibition of lipoprotein lipase activity by a monoclonal immunoglobulin in autoimmune hyperlipidemia. Atherosclerosis. 1977 Jan;26(1):67–77. doi: 10.1016/0021-9150(77)90141-1. [DOI] [PubMed] [Google Scholar]
  4. Beisiegel U., Schneider W. J., Goldstein J. L., Anderson R. G., Brown M. S. Monoclonal antibodies to the low density lipoprotein receptor as probes for study of receptor-mediated endocytosis and the genetics of familial hypercholesterolemia. J Biol Chem. 1981 Nov 25;256(22):11923–11931. [PubMed] [Google Scholar]
  5. Biesbroeck R., Oram J. F., Albers J. J., Bierman E. L. Specific high-affinity binding of high density lipoproteins to cultured human skin fibroblasts and arterial smooth muscle cells. J Clin Invest. 1983 Mar;71(3):525–539. doi: 10.1172/JCI110797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bilheimer D. W., Eisenberg S., Levy R. I. The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. Biochim Biophys Acta. 1972 Feb 21;260(2):212–221. doi: 10.1016/0005-2760(72)90034-3. [DOI] [PubMed] [Google Scholar]
  7. Burnette W. N. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem. 1981 Apr;112(2):195–203. doi: 10.1016/0003-2697(81)90281-5. [DOI] [PubMed] [Google Scholar]
  8. Chacko G. K. Characterization of high-density lipoprotein binding sites in rat liver and testis membranes. Biochim Biophys Acta. 1984 Sep 12;795(2):417–426. doi: 10.1016/0005-2760(84)90093-6. [DOI] [PubMed] [Google Scholar]
  9. Daniel T. O., Schneider W. J., Goldstein J. L., Brown M. S. Visualization of lipoprotein receptors by ligand blotting. J Biol Chem. 1983 Apr 10;258(7):4606–4611. [PubMed] [Google Scholar]
  10. Fraker P. J., Speck J. C., Jr Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun. 1978 Feb 28;80(4):849–857. doi: 10.1016/0006-291x(78)91322-0. [DOI] [PubMed] [Google Scholar]
  11. Goldstein J. L., Basu S. K., Brown M. S. Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol. 1983;98:241–260. doi: 10.1016/0076-6879(83)98152-1. [DOI] [PubMed] [Google Scholar]
  12. HAVEL R. J., EDER H. A., BRAGDON J. H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955 Sep;34(9):1345–1353. doi: 10.1172/JCI103182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kilgore L. L., Patterson B. W., Parenti D. M., Fisher W. R. Immune complex hyperlipidemia induced by an apolipoprotein-reactive immunoglobulin A paraprotein from a patient with multiple myeloma. Characterization of this immunoglobulin. J Clin Invest. 1985 Jul;76(1):225–232. doi: 10.1172/JCI111951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kita T., Beisiegel U., Goldstein J. L., Schneider W. J., Brown M. S. Antibody against low density lipoprotein receptor blocks uptake of low density lipoprotein (but not high density lipoprotein) by the adrenal gland of the mouse in vivo. J Biol Chem. 1981 May 25;256(10):4701–4703. [PubMed] [Google Scholar]
  15. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  16. Lewis L. A., deWolfe V. D., Butkus A., Page I. H. Autoimmune hyperlipidemia in a patient. Atherosclerotic course and chaning immunoglobulin pattern during 21 years of study. Am J Med. 1975 Aug;59(2):208–218. doi: 10.1016/0002-9343(75)90355-1. [DOI] [PubMed] [Google Scholar]
  17. Milne R. W., Theolis R., Jr, Verdery R. B., Marcel Y. L. Characterization of monoclonal antibodies against human low density lipoprotein. Arteriosclerosis. 1983 Jan-Feb;3(1):23–30. doi: 10.1161/01.atv.3.1.23. [DOI] [PubMed] [Google Scholar]
  18. Riesen W., Noseda G. Antibodies against lipoproteins in man. Occurrence and biological significance. Klin Wochenschr. 1975 Apr 15;53(8):353–361. doi: 10.1007/BF01468673. [DOI] [PubMed] [Google Scholar]
  19. Schneider W. J., Goldstein J. L., Brown M. S. Partial purification and characterization of the low density lipoprotein receptor from bovine adrenal cortex. J Biol Chem. 1980 Dec 10;255(23):11442–11447. [PubMed] [Google Scholar]
  20. Taylor S. I., Grunberger G., Marcus-Samuels B., Underhill L. H., Dons R. F., Ryan J., Roddam R. F., Rupe C. E., Gorden P. Hypoglycemia associated with antibodies to the insulin receptor. N Engl J Med. 1982 Dec 2;307(23):1422–1426. doi: 10.1056/NEJM198212023072303. [DOI] [PubMed] [Google Scholar]
  21. Thompson G. R., Soutar A. K., Spengel F. A., Jadhav A., Gavigan S. J., Myant N. B. Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo. Proc Natl Acad Sci U S A. 1981 Apr;78(4):2591–2595. doi: 10.1073/pnas.78.4.2591. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Tikkanen N. J., Dargar R., Pfleger B., Gonen B., Davie J. M., Schonfeld G. Antigenic mapping of human low density lipoprotein with monoclonal antibodies. J Lipid Res. 1982 Sep;23(7):1032–1038. [PubMed] [Google Scholar]
  23. Weisgraber K. H., Mahley R. W. Subfractionation of human high density lipoproteins by heparin-Sepharose affinity chromatography. J Lipid Res. 1980 Mar;21(3):316–325. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES